Pain Medications: Differences Between the Sexes

Principles of Gender-Specific Medicine

Volumn 2, Issue , 2004, Pages 843-847

  Miaskowski, Christine ^a   Levine, Jon D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33645636037     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012440905-7/50348-0     Document Type: Chapter

References (42)

1. Riley JL, Robinson ME, Wise EA, et al. Sex differences in the perception of noxious experimental stimuli: A meta-analysis. Pain. 1998, 74:181-187.
2. Berkley KJ Sex differences in pain. Behav Brain Sci. 1997, 20:371-380.
3. Unruh AM Gender variations in clinical pain experience. Pain. 1996, 65:123-167.
4. Miaskowski C, Gear RW, Levine JD Sex-related differences in analgesic responses. Sex, Gender, and Pain 2000, 209-230. IASP Press, Seattle. R.B. Fillingim (Ed.).
5. Kest B, Sarton E, Dahan A Gender differences in opioid-mediated analgesia: Animal and human studies. Anesthesiology. 2000, 93:539-547.
6. Barsky AJ, Peekna HM, Borus JF Somatic symptom reporting in women and men. J Gen Intern Med. 2001, 16:266-276.
7. van Wijk CM, Kolk AM Sex differences in physical symptoms: The contribution of symptom perception theory. Soc Sci Med. 1997, 45:231-246.
8. Kroenke K, Price RK Symptoms in the community. Arch Intern Med. 1993, 153:2474-2480.
9. Verbrugge LM, Ascione FJ Exploring the iceberg: Common symptoms and how people care for them. Med Care. 1987, 25:539-569.
10. Calderone KL The influence of gender on frequency of pain and sedative medication administered to postoperative patients. Sex Roles 1990, 23:713-725.
11. Cleeland CS, Gonin R, Hatfield AK, et al. Pain and its treatment in outpatients with metastatic cancer. N Engl J Med. 1994, 330:592-596.
12. Breitbart W, Rosenfeld BD, Passik SD, et al. The undertreatment of pain in ambulatory AIDS patients. Pain. 1996, 65:243-249.
13. McQuay HJ, Bullingham RES, Paterson GMC, Moore RA Clinical effects of buprenorphine during and after operation. Br J Anaesth. 1980, 52:1013-1019.
14. Bullingham RES, McQuay HJ, Dwyer D, et al. Sublingual buprenorphine used postoperatively: Clinical observations and preliminary pharmacokinetics analysis. Br J Clin Pharmacol. 1981, 12:117-122.
15. Watson PJQ, McQuay HJ, Bullingham RES, et al. Single-dose comparison of buprenorphine 0.3 and 0.6 mg I.V. Given after operation: Clinical effects and plasma concentrations. Br J Anaesth 1982, 54:37-43.
16. Bennett R, Batenhorst R, Graves DA, et al. Variation in postoperative analgesic requirements in the morbidly obese following gastric bypass surgery. Pharmacotherapy 1982, 2:50-53.
17. Tamsen A, Bondesson U, Dahlstrom B, Hartvig P Patient controlled analgesic therapy, Part III: Pharmacokinetics and analgesic plasma concentrations of ketobemidone. Clin Pharmacokinet 1982, 7:151-165.
18. Tamsen A, Hartvig P, Fagerlund C, Dahlstrom B Patient controlled analgesic therapy, Part I: Pharmacokinetics of pethidine in the pre-and postoperative periods. Clin Pharmacokinet. 1982, 7:149-163.
19. Dahlstrom B, Tamsen A, Paalzow L, Hartvig P. Patient-controlled analgesic therapy, Part IV: Pharmacokinetics and analgesic plasma concentrations of morphine. Clin Pharmacokinet. 1982, 7:266-279.
20. Bahar M, Rsen M, Vickers MD Self-administered nalbuphine, morphine, and pethidine. Anesthesia. 1985, 40:529-532.
21. Lehmann KA, Tenbuhs B Patient-controlled analgesia with nalbuphine, a new narcotic agonist-antagonist, for the treatment of postoperative pain. Eur J Clin Pharmacol. 1986, 31:267-276.
22. Gourlay GK, Kowalski SR, Plummer JL, et al. Fentanyl blood concentrations-analgesic response relationship in the treatment of postoperative pain. Anesth Analg. 1988, 67:329-337.
23. Burns JW, Hodsman NBA, McLintock TT, et al. The influence of patient characteristics on the requirements for postoperative analgesia: A reassessment using patient-controlled analgesia. Anesthesia. 1989, 44:2-6.
24. De Kock M, Scholtes JL Postoperative PCA in abdominal surgery. Analysis of 200 consecutive patients. Acta Anaesthesiol Belg. 1991, 42:85-91.
25. Tsui SL, Tong WN, Irwin M, et al. The efficacy, applicability, and side effects of postoperative intravenous patient-controlled morphine analgesia: an audit of 1233 Chinese patients. Anaesth Intens Care. 1996, 24:658-664.
26. Sidebotham D, Dijkhuizen MRJ, Schug SA The safety and utilization of patient controlled analgesia. J Pain Symptom Manage. 1997, 14:202-209.
27. Boethius G. Recording of drug prescriptions in the county of Jamtland, Sweden. Acta Med Scand. 1977, 202:241-251.
28. Klaukka T Uses of prescription drugs in Finnish primary care. Scand J Prim Health Care. 1988, 6:43-50.
29. Ahonen R, Enlund H, Klaukka T, Vohlonen I Use of analgesics in a rural Finnish population. J Pharmacoepidemiol. 1991, 2:3-17.
30. Eggen AE The Tromso study: Frequency and predicting factors of analgesic drug use in a free-living population (12-56 years). J Clin Epidemiol. 1993, 46:1297-1304.
31. Turk DC, Okifuji A Does sex make a difference in the prescription of treatments and the adaptation to chronic pain by cancer and non-cancer patients?. Pain. 1999, 82:139-148.
32. Fillingim RB, Doleys DM, Edwards RR, Lowery D Clinical characteristics of chronic back pain as a function of gender and oral opiod use. Spine. 2003, 28:143-150.
33. Kerns RD, Turk DC, Rudy TE The West Haven-Yale Multidimensional Pain Inventory (WHYMPI). Pain. 1985, 23:345-356.
34. Walker JS, Carmody JJ Experimental pain in healthy human subjects: Gender differences in nociception and in response to ibuprofen. Anesth Anal. 1998, 86:1257-1262.
35. Walker JS NASIDS: An update on their analgesic effects. Clin Exp Physiol Pharmacol. 1995, 22:855-860.
36. Gordon NC, Gear RW, Heller PH, et al. Enhancement of morphine analgesia by the GABA-B agonist baclofen. Neuroscience. 1995, 69:345-349.
37. Gear RW, Gordon NC, Heller PH, et al. Gender difference in analgesic response to the kappa-opioid pentazocine. Neurosci Lett. 1996, 205:207-209.
38. Gear RW, Miaskowski C, Gordon NC, et al. Kappa-opioid produce significantly greater analgesia in women than in men. Nat Med. 1996, 2:1248-1250.
39. Gear RW, Miaskowski C, Gordon NC, et al. The kappa-opioid nalbuphine produces gender and dose dependent analgesia and antianalgesia in patients with postoperative pain. Pain. 1999, 83:339-345.
40. Sarton E, Olofsen E, Romberg R, et al. Sex differences in morphine analgesia-an experimental study in healthy volunteers. Anesthesiology. 2002, 93:1245-1254.
41. Dahan A, Sarton E, Teppema L, Olievier C Sex-related differences in the influence of morphine on ventilatory control in humans. Anesthesiology. 1998, 88:903-913.
42. Zun LS, Downey LV, Gossman W, et al. Gender differences in narcotic-induced emesis in the ED. Am J Emerg Med. 2002, 20:151-154.